CEAT Limited has informed the Exchange regarding Updates of the Board Meeting Dated January 19, 2022 - Regulation 30.
The Karnataka Bank Limited has informed the Exchange regarding a press release dated January 20, 2022, titled Karnataka Bank launches Online KYC updation portal.
Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 20, 2022, titled Zydus receives final approval from USFDA for Vigabatrin Tablets.
Coastal Corporation Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
SBI Life Insurance Company Limited has informed the Exchange about Schedule of meet
Sterling And Wilson Solar Limited has informed the Exchange about Schedule of meet
Brigade Enterprises Limited has informed the Exchange about Schedule of meet
JSW Ispat Special Products Limited has informed the Exchange regarding Board meeting held on January 19, 2022.
SMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 20, 2022, titled we are enclosing here with press release dated 20th January, 2022 regarding the Company receives non-exclusive license to manufacture and supply of molnupiravir (an oral COVID 19 medicine) through the medicine patent pool(MPP).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
